Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Clinical trial NCT05332340 · COMPLETED

Trial details

NCT number: NCT05332340
Sponsor: Biozeus Biopharmaceutical S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Erectile Dysfunction Following Radical Prostatectomy Erectile Dysfunction Prostate Cancer Radical Prostatectomy

Start date: 2022-11-16
Primary completion: 2022-11-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.